APO Research
Talk to an analyst

APO RESEARCH · REPORT

Indapamide

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Indapamide Market Analysis and Forecast 2026-2032

20 December 2025192 pages

Choose your research edition.

Industry ResearchIndapamide Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Indapamide Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Indapamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Indapamide Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Indapamide Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Indapamide market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Indapamide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Indapamide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Indapamide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Indapamide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Indapamide include ANI Pharma, Apeloa Kangyu, Cigna, Glenmark Pharmaceuticals, Servier, Supra Chemicals, Taj Pharmaceuticals, Mylan and Shandong Yinfeida Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Indapamide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Indapamide, also provides the sales of main regions and countries. Of the upcoming market potential for Indapamide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Indapamide sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Indapamide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Indapamide sales, projected growth trends, production technology, application and end-user industry.

Indapamide Segment by Company

ANI Pharma

Apeloa Kangyu

Cigna

Glenmark Pharmaceuticals

Servier

Supra Chemicals

Taj Pharmaceuticals

Mylan

Shandong Yinfeida Pharmaceutical

Suzhou Lixinpharm

Teva

Lisheng Pharma

Indapamide Segment by Type

1.25 mg Indapamide Tablets

2.5 mg Indapamide Tablets

Indapamide Segment by Application

Diuretic

Hypertension Treatment

Other

Indapamide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Indapamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Indapamide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Indapamide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Indapamide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Indapamide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Indapamide sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Indapamide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 1.25 mg Indapamide Tablets Major Manufacturers Table 3. 2.5 mg Indapamide Tablets Major Manufacturers Table 4. Global Indapamide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Diuretic Major Manufacturers Table 6. Hypertension Treatment Major Manufacturers Table 7. Other Major Manufacturers Table 8. Indapamide Industry Trends Table 9. Indapamide Industry Drivers Table 10. Indapamide Industry Opportunities and Challenges Table 11. Indapamide Industry Restraints Table 12. Global Indapamide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Indapamide Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Indapamide Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Indapamide Revenue Market Share by Region (2021-2026) Table 16. Global Indapamide Revenue Market Share by Region (2027-2032) Table 17. Global Indapamide Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Tons) Table 18. Global Indapamide Sales by Region (2021-2026) & (K Tons) Table 19. Global Indapamide Sales by Region (2027-2032) & (K Tons) Table 20. Global Indapamide Sales Market Share by Region (2021-2026) Table 21. Global Indapamide Sales Market Share by Region (2027-2032) Table 22. Global Indapamide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Indapamide Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Indapamide Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Indapamide Sales Market Share by Manufacturers (2021-2026) Table 26. Global Indapamide Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 27. Global Indapamide Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Indapamide Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Indapamide Manufacturers, Product Type & Application Table 30. Global Indapamide Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Indapamide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Indapamide Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Indapamide Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Indapamide Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Indapamide Revenue Market Share by Type (2021-2026) Table 37. Global Indapamide Revenue Market Share by Type (2027-2032) Table 38. Global Indapamide Sales by Type 2021 VS 2025 VS 2032 (K Tons) Table 39. Global Indapamide Sales by Type (2021-2026) & (K Tons) Table 40. Global Indapamide Sales by Type (2027-2032) & (K Tons) Table 41. Global Indapamide Sales Market Share by Type (2021-2026) Table 42. Global Indapamide Sales Market Share by Type (2027-2032) Table 43. Global Indapamide Price by Type (2021-2026) & (US$/Ton) Table 44. Global Indapamide Price by Type (2027-2032) & (US$/Ton) Table 45. Global Indapamide Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Indapamide Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Indapamide Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Indapamide Revenue Market Share by Application (2021-2026) Table 49. Global Indapamide Revenue Market Share by Application (2027-2032) Table 50. Global Indapamide Sales by Application 2021 VS 2025 VS 2032 (K Tons) Table 51. Global Indapamide Sales by Application (2021-2026) & (K Tons) Table 52. Global Indapamide Sales by Application (2027-2032) & (K Tons) Table 53. Global Indapamide Sales Market Share by Application (2021-2026) Table 54. Global Indapamide Sales Market Share by Application (2027-2032) Table 55. Global Indapamide Price by Application (2021-2026) & (US$/Ton) Table 56. Global Indapamide Price by Application (2027-2032) & (US$/Ton) Table 57. ANI Pharma Company Information Table 58. ANI Pharma Business Overview Table 59. ANI Pharma Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 60. ANI Pharma Indapamide Product Portfolio Table 61. ANI Pharma Recent Development Table 62. Apeloa Kangyu Company Information Table 63. Apeloa Kangyu Business Overview Table 64. Apeloa Kangyu Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 65. Apeloa Kangyu Indapamide Product Portfolio Table 66. Apeloa Kangyu Recent Development Table 67. Cigna Company Information Table 68. Cigna Business Overview Table 69. Cigna Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 70. Cigna Indapamide Product Portfolio Table 71. Cigna Recent Development Table 72. Glenmark Pharmaceuticals Company Information Table 73. Glenmark Pharmaceuticals Business Overview Table 74. Glenmark Pharmaceuticals Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Glenmark Pharmaceuticals Indapamide Product Portfolio Table 76. Glenmark Pharmaceuticals Recent Development Table 77. Servier Company Information Table 78. Servier Business Overview Table 79. Servier Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Servier Indapamide Product Portfolio Table 81. Servier Recent Development Table 82. Supra Chemicals Company Information Table 83. Supra Chemicals Business Overview Table 84. Supra Chemicals Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Supra Chemicals Indapamide Product Portfolio Table 86. Supra Chemicals Recent Development Table 87. Taj Pharmaceuticals Company Information Table 88. Taj Pharmaceuticals Business Overview Table 89. Taj Pharmaceuticals Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Taj Pharmaceuticals Indapamide Product Portfolio Table 91. Taj Pharmaceuticals Recent Development Table 92. Mylan Company Information Table 93. Mylan Business Overview Table 94. Mylan Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Mylan Indapamide Product Portfolio Table 96. Mylan Recent Development Table 97. Shandong Yinfeida Pharmaceutical Company Information Table 98. Shandong Yinfeida Pharmaceutical Business Overview Table 99. Shandong Yinfeida Pharmaceutical Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Shandong Yinfeida Pharmaceutical Indapamide Product Portfolio Table 101. Shandong Yinfeida Pharmaceutical Recent Development Table 102. Suzhou Lixinpharm Company Information Table 103. Suzhou Lixinpharm Business Overview Table 104. Suzhou Lixinpharm Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. Suzhou Lixinpharm Indapamide Product Portfolio Table 106. Suzhou Lixinpharm Recent Development Table 107. Teva Company Information Table 108. Teva Business Overview Table 109. Teva Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 110. Teva Indapamide Product Portfolio Table 111. Teva Recent Development Table 112. Lisheng Pharma Company Information Table 113. Lisheng Pharma Business Overview Table 114. Lisheng Pharma Indapamide Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 115. Lisheng Pharma Indapamide Product Portfolio Table 116. Lisheng Pharma Recent Development Table 117. North America Indapamide Revenue by Type (2021-2026) & (US$ Million) Table 118. North America Indapamide Revenue by Type (2027-2032) & (US$ Million) Table 119. North America Indapamide Sales by Type (2021-2026) & (K Tons) Table 120. North America Indapamide Sales by Type (2027-2032) & (K Tons) Table 121. North America Indapamide Sales Price by Type (2021-2026) & (US$/Ton) Table 122. North America Indapamide Sales Price by Type (2027-2032) & (US$/Ton) Table 123. North America Indapamide Revenue by Application (2021-2026) & (US$ Million) Table 124. North America Indapamide Revenue by Application (2027-2032) & (US$ Million) Table 125. North America Indapamide Sales by Application (2021-2026) & (K Tons) Table 126. North America Indapamide Sales by Application (2027-2032) & (K Tons) Table 127. North America Indapamide Sales Price by Application (2021-2026) & (US$/Ton) Table 128. North America Indapamide Sales Price by Application (2027-2032) & (US$/Ton) Table 129. North America Indapamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Indapamide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 131. North America Indapamide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 132. North America Indapamide Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 133. North America Indapamide Sales by Country (2021-2026) & (K Tons) Table 134. North America Indapamide Sales by Country (2027-2032) & (K Tons) Table 135. North America Indapamide Sales Price by Country (2021-2026) & (US$/Ton) Table 136. North America Indapamide Sales Price by Country (2027-2032) & (US$/Ton) Table 137. United States Indapamide Revenue (2021-2032) & (US$ Million) Table 138. Canada Indapamide Revenue (2021-2032) & (US$ Million) Table 139. Europe Indapamide Revenue by Type (2021-2026) & (US$ Million) Table 140. Europe Indapamide Revenue by Type (2027-2032) & (US$ Million) Table 141. Europe Indapamide Sales by Type (2021-2026) & (K Tons) Table 142. Europe Indapamide Sales by Type (2027-2032) & (K Tons) Table 143. Europe Indapamide Sales Price by Type (2021-2026) & (US$/Ton) Table 144. Europe Indapamide Sales Price by Type (2027-2032) & (US$/Ton) Table 145. Europe Indapamide Revenue by Application (2021-2026) & (US$ Million) Table 146. Europe Indapamide Revenue by Application (2027-2032) & (US$ Million) Table 147. Europe Indapamide Sales by Application (2021-2026) & (K Tons) Table 148. Europe Indapamide Sales by Application (2027-2032) & (K Tons) Table 149. Europe Indapamide Sales Price by Application (2021-2026) & (US$/Ton) Table 150. Europe Indapamide Sales Price by Application (2027-2032) & (US$/Ton) Table 151. Europe Indapamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Europe Indapamide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 153. Europe Indapamide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 154. Europe Indapamide Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 155. Europe Indapamide Sales by Country (2021-2026) & (K Tons) Table 156. Europe Indapamide Sales by Country (2027-2032) & (K Tons) Table 157. Europe Indapamide Sales Price by Country (2021-2026) & (US$/Ton) Table 158. Europe Indapamide Sales Price by Country (2027-2032) & (US$/Ton) Table 159. Germany Indapamide Revenue (2021-2032) & (US$ Million) Table 160. France Indapamide Revenue (2021-2032) & (US$ Million) Table 161. U.K. Indapamide Revenue (2021-2032) & (US$ Million) Table 162. Italy Indapamide Revenue (2021-2032) & (US$ Million) Table 163. Netherlands Indapamide Revenue (2021-2032) & (US$ Million) Table 164. China Indapamide Revenue by Type (2021-2026) & (US$ Million) Table 165. China Indapamide Revenue by Type (2027-2032) & (US$ Million) Table 166. China Indapamide Sales by Type (2021-2026) & (K Tons) Table 167. China Indapamide Sales by Type (2027-2032) & (K Tons) Table 168. China Indapamide Sales Price by Type (2021-2026) & (US$/Ton) Table 169. China Indapamide Sales Price by Type (2027-2032) & (US$/Ton) Table 170. China Indapamide Revenue by Application (2021-2026) & (US$ Million) Table 171. China Indapamide Revenue by Application (2027-2032) & (US$ Million) Table 172. China Indapamide Sales by Application (2021-2026) & (K Tons) Table 173. China Indapamide Sales by Application (2027-2032) & (K Tons) Table 174. China Indapamide Sales Price by Application (2021-2026) & (US$/Ton) Table 175. China Indapamide Sales Price by Application (2027-2032) & (US$/Ton) Table 176. Asia Indapamide Revenue by Type (2021-2026) & (US$ Million) Table 177. Asia Indapamide Revenue by Type (2027-2032) & (US$ Million) Table 178. Asia Indapamide Sales by Type (2021-2026) & (K Tons) Table 179. Asia Indapamide Sales by Type (2027-2032) & (K Tons) Table 180. Asia Indapamide Sales Price by Type (2021-2026) & (US$/Ton) Table 181. Asia Indapamide Sales Price by Type (2027-2032) & (US$/Ton) Table 182. Asia Indapamide Revenue by Application (2021-2026) & (US$ Million) Table 183. Asia Indapamide Revenue by Application (2027-2032) & (US$ Million) Table 184. Asia Indapamide Sales by Application (2021-2026) & (K Tons) Table 185. Asia Indapamide Sales by Application (2027-2032) & (K Tons) Table 186. Asia Indapamide Sales Price by Application (2021-2026) & (US$/Ton) Table 187. Asia Indapamide Sales Price by Application (2027-2032) & (US$/Ton) Table 188. Asia Indapamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 189. Asia Indapamide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 190. Asia Indapamide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 191. Asia Indapamide Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 192. Asia Indapamide Sales by Country (2021-2026) & (K Tons) Table 193. Asia Indapamide Sales by Country (2027-2032) & (K Tons) Table 194. Asia Indapamide Sales Price by Country (2021-2026) & (US$/Ton) Table 195. Asia Indapamide Sales Price by Country (2027-2032) & (US$/Ton) Table 196. Japan Indapamide Revenue (2021-2032) & (US$ Million) Table 197. South Korea Indapamide Revenue (2021-2032) & (US$ Million) Table 198. India Indapamide Revenue (2021-2032) & (US$ Million) Table 199. Australia Indapamide Revenue (2021-2032) & (US$ Million) Table 200. China Taiwan Indapamide Revenue (2021-2032) & (US$ Million) Table 201. Southeast Asia Indapamide Revenue (2021-2032) & (US$ Million) Table 202. SAMEA Indapamide Revenue by Type (2021-2026) & (US$ Million) Table 203. SAMEA Indapamide Revenue by Type (2027-2032) & (US$ Million) Table 204. SAMEA Indapamide Sales by Type (2021-2026) & (K Tons) Table 205. SAMEA Indapamide Sales by Type (2027-2032) & (K Tons) Table 206. SAMEA Indapamide Sales Price by Type (2021-2026) & (US$/Ton) Table 207. SAMEA Indapamide Sales Price by Type (2027-2032) & (US$/Ton) Table 208. SAMEA Indapamide Revenue by Application (2021-2026) & (US$ Million) Table 209. SAMEA Indapamide Revenue by Application (2027-2032) & (US$ Million) Table 210. SAMEA Indapamide Sales by Application (2021-2026) & (K Tons) Table 211. SAMEA Indapamide Sales by Application (2027-2032) & (K Tons) Table 212. SAMEA Indapamide Sales Price by Application (2021-2026) & (US$/Ton) Table 213. SAMEA Indapamide Sales Price by Application (2027-2032) & (US$/Ton) Table 214. SAMEA Indapamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 215. SAMEA Indapamide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 216. SAMEA Indapamide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 217. SAMEA Indapamide Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 218. SAMEA Indapamide Sales by Country (2021-2026) & (K Tons) Table 219. SAMEA Indapamide Sales by Country (2027-2032) & (K Tons) Table 220. SAMEA Indapamide Sales Price by Country (2021-2026) & (US$/Ton) Table 221. SAMEA Indapamide Sales Price by Country (2027-2032) & (US$/Ton) Table 222. Brazil Indapamide Revenue (2021-2032) & (US$ Million) Table 223. Argentina Indapamide Revenue (2021-2032) & (US$ Million) Table 224. Chile Indapamide Revenue (2021-2032) & (US$ Million) Table 225. Colombia Indapamide Revenue (2021-2032) & (US$ Million) Table 226. Peru Indapamide Revenue (2021-2032) & (US$ Million) Table 227. Saudi Arabia Indapamide Revenue (2021-2032) & (US$ Million) Table 228. Israel Indapamide Revenue (2021-2032) & (US$ Million) Table 229. UAE Indapamide Revenue (2021-2032) & (US$ Million) Table 230. Turkey Indapamide Revenue (2021-2032) & (US$ Million) Table 231. Iran Indapamide Revenue (2021-2032) & (US$ Million) Table 232. Egypt Indapamide Revenue (2021-2032) & (US$ Million) Table 233. Key Raw Materials Table 234. Raw Materials Key Suppliers Table 235. Indapamide Distributors List Table 236. Indapamide Customers List Table 237. Research Programs/Design for This Report Table 238. Authors List of This Report Table 239. Secondary Sources Table 240. Primary Sources List of Figures Figure 1. Indapamide Image Figure 2. Global Indapamide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Indapamide Market Size Share 2021 VS 2025 VS 2032 Figure 4. 1.25 mg Indapamide Tablets Image Figure 5. 2.5 mg Indapamide Tablets Image Figure 6. Global Indapamide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Indapamide Market Size Share 2021 VS 2025 VS 2032 Figure 8. Diuretic Image Figure 9. Hypertension Treatment Image Figure 10. Other Image Figure 11. Global Indapamide Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Indapamide Revenue (2021-2032) & (US$ Million) Figure 13. Global Indapamide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Indapamide Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Indapamide Revenue Market Share by Region (2021-2032) Figure 16. Global Indapamide Sales (2021-2032) & (K Tons) Figure 17. Global Indapamide Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Figure 18. Global Indapamide Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Indapamide Sales YoY (2021-2032) & (K Tons) Figure 20. Europe Indapamide Sales YoY (2021-2032) & (K Tons) Figure 21. China Indapamide Sales YoY (2021-2032) & (K Tons) Figure 22. Asia (Excluding China) Indapamide Sales YoY (2021-2032) & (K Tons) Figure 23. South America, Middle East and Africa Indapamide Sales YoY (2021-2032) & (K Tons) Figure 24. Global Indapamide Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Indapamide Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Indapamide Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Indapamide Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Indapamide Revenue Market Share by Type (2021-2032) Figure 30. Global Indapamide Sales by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 31. Global Indapamide Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Indapamide Sales Market Share by Type (2021-2032) Figure 33. Global Indapamide Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Indapamide Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Indapamide Revenue Market Share by Application (2021-2032) Figure 36. Global Indapamide Sales by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 37. Global Indapamide Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Indapamide Sales Market Share by Application (2021-2032) Figure 39. North America Indapamide Revenue Share by Type (2021-2032) Figure 40. North America Indapamide Sales Share by Type (2021-2032) Figure 41. North America Indapamide Revenue Share by Application (2021-2032) Figure 42. North America Indapamide Sales Share by Application (2021-2032) Figure 43. North America Indapamide Revenue Share by Country (2021-2032) Figure 44. North America Indapamide Sales Share by Country (2021-2032) Figure 45. Europe Indapamide Revenue Share by Type (2021-2032) Figure 46. Europe Indapamide Sales Share by Type (2021-2032) Figure 47. Europe Indapamide Revenue Share by Application (2021-2032) Figure 48. Europe Indapamide Sales Share by Application (2021-2032) Figure 49. Europe Indapamide Revenue Share by Country (2021-2032) Figure 50. Europe Indapamide Sales Share by Country (2021-2032) Figure 51. China Indapamide Revenue Share by Type (2021-2032) Figure 52. China Indapamide Sales Share by Type (2021-2032) Figure 53. China Indapamide Revenue Share by Application (2021-2032) Figure 54. China Indapamide Sales Share by Application (2021-2032) Figure 55. Asia Indapamide Revenue Share by Type (2021-2032) Figure 56. Asia Indapamide Sales Share by Type (2021-2032) Figure 57. Asia Indapamide Revenue Share by Application (2021-2032) Figure 58. Asia Indapamide Sales Share by Application (2021-2032) Figure 59. Asia Indapamide Revenue Share by Country (2021-2032) Figure 60. Asia Indapamide Sales Share by Country (2021-2032) Figure 61. SAMEA Indapamide Revenue Share by Type (2021-2032) Figure 62. SAMEA Indapamide Sales Share by Type (2021-2032) Figure 63. SAMEA Indapamide Revenue Share by Application (2021-2032) Figure 64. SAMEA Indapamide Sales Share by Application (2021-2032) Figure 65. SAMEA Indapamide Revenue Share by Country (2021-2032) Figure 66. SAMEA Indapamide Sales Share by Country (2021-2032) Figure 67. Indapamide Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Indapamide Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 1.25 mg Indapamide Tablets
  • 2.5 mg Indapamide Tablets
Applications
  • Diuretic
  • Hypertension Treatment
  • Other
Companies covered
  • ANI Pharma
  • Apeloa Kangyu
  • Cigna
  • Glenmark Pharmaceuticals
  • Servier
  • Supra Chemicals
  • Taj Pharmaceuticals
  • Mylan
  • Shandong Yinfeida Pharmaceutical
  • Suzhou Lixinpharm
  • Teva
  • Lisheng Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Indapamide Market by Type
  3. 1.2.1 Global Indapamide Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 1.25 mg Indapamide Tablets
  5. 1.2.3 2.5 mg Indapamide Tablets
  6. 1.3 Indapamide Market by Application
  7. 1.3.1 Global Indapamide Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Diuretic
  9. 1.3.3 Hypertension Treatment
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Indapamide Market Dynamics
  1. 2.1 Indapamide Industry Trends
  2. 2.2 Indapamide Industry Drivers
  3. 2.3 Indapamide Industry Opportunities and Challenges
  4. 2.4 Indapamide Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Indapamide Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Indapamide Revenue by Region
  3. 3.2.1 Global Indapamide Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Indapamide Revenue by Region (2021-2026)
  5. 3.2.3 Global Indapamide Revenue by Region (2027-2032)
  6. 3.2.4 Global Indapamide Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Indapamide Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Indapamide Sales by Region
  9. 3.4.1 Global Indapamide Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Indapamide Sales by Region (2021-2026)
  11. 3.4.3 Global Indapamide Sales by Region (2027-2032)
  12. 3.4.4 Global Indapamide Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Indapamide Revenue by Manufacturers
  2. 4.1.1 Global Indapamide Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Indapamide Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Indapamide Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Indapamide Sales by Manufacturers
  6. 4.2.1 Global Indapamide Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Indapamide Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Indapamide Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Indapamide Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Indapamide Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Indapamide Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Indapamide Manufacturers, Product Type & Application
  13. 4.7 Global Indapamide Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Indapamide Market CR5 and HHI
  16. 4.8.2 2025 Indapamide Tier 1, Tier 2, and Tier 3
5 Indapamide Market by Type
  1. 5.1 Global Indapamide Revenue by Type
  2. 5.1.1 Global Indapamide Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Indapamide Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Indapamide Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Indapamide Sales by Type
  6. 5.2.1 Global Indapamide Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Indapamide Sales by Type (2021-2032) & (K Tons)
  8. 5.2.3 Global Indapamide Sales Market Share by Type (2021-2032)
  9. 5.3 Global Indapamide Price by Type
6 Indapamide Market by Application
  1. 6.1 Global Indapamide Revenue by Application
  2. 6.1.1 Global Indapamide Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Indapamide Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Indapamide Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Indapamide Sales by Application
  6. 6.2.1 Global Indapamide Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Indapamide Sales by Application (2021-2032) & (K Tons)
  8. 6.2.3 Global Indapamide Sales Market Share by Application (2021-2032)
  9. 6.3 Global Indapamide Price by Application
7 Company Profiles
  1. 7.1 ANI Pharma
  2. 7.1.1 ANI Pharma Company Information
  3. 7.1.2 ANI Pharma Business Overview
  4. 7.1.3 ANI Pharma Indapamide Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 ANI Pharma Indapamide Product Portfolio
  6. 7.1.5 ANI Pharma Recent Developments
  7. 7.2 Apeloa Kangyu
  8. 7.2.1 Apeloa Kangyu Company Information
  9. 7.2.2 Apeloa Kangyu Business Overview
  10. 7.2.3 Apeloa Kangyu Indapamide Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Apeloa Kangyu Indapamide Product Portfolio
  12. 7.2.5 Apeloa Kangyu Recent Developments
  13. 7.3 Cigna
  14. 7.3.1 Cigna Company Information
  15. 7.3.2 Cigna Business Overview
  16. 7.3.3 Cigna Indapamide Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Cigna Indapamide Product Portfolio
  18. 7.3.5 Cigna Recent Developments
  19. 7.4 Glenmark Pharmaceuticals
  20. 7.4.1 Glenmark Pharmaceuticals Company Information
  21. 7.4.2 Glenmark Pharmaceuticals Business Overview
  22. 7.4.3 Glenmark Pharmaceuticals Indapamide Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Glenmark Pharmaceuticals Indapamide Product Portfolio
  24. 7.4.5 Glenmark Pharmaceuticals Recent Developments
  25. 7.5 Servier
  26. 7.5.1 Servier Company Information
  27. 7.5.2 Servier Business Overview
  28. 7.5.3 Servier Indapamide Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Servier Indapamide Product Portfolio
  30. 7.5.5 Servier Recent Developments
  31. 7.6 Supra Chemicals
  32. 7.6.1 Supra Chemicals Company Information
  33. 7.6.2 Supra Chemicals Business Overview
  34. 7.6.3 Supra Chemicals Indapamide Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Supra Chemicals Indapamide Product Portfolio
  36. 7.6.5 Supra Chemicals Recent Developments
  37. 7.7 Taj Pharmaceuticals
  38. 7.7.1 Taj Pharmaceuticals Company Information
  39. 7.7.2 Taj Pharmaceuticals Business Overview
  40. 7.7.3 Taj Pharmaceuticals Indapamide Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Taj Pharmaceuticals Indapamide Product Portfolio
  42. 7.7.5 Taj Pharmaceuticals Recent Developments
  43. 7.8 Mylan
  44. 7.8.1 Mylan Company Information
  45. 7.8.2 Mylan Business Overview
  46. 7.8.3 Mylan Indapamide Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Mylan Indapamide Product Portfolio
  48. 7.8.5 Mylan Recent Developments
  49. 7.9 Shandong Yinfeida Pharmaceutical
  50. 7.9.1 Shandong Yinfeida Pharmaceutical Company Information
  51. 7.9.2 Shandong Yinfeida Pharmaceutical Business Overview
  52. 7.9.3 Shandong Yinfeida Pharmaceutical Indapamide Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Shandong Yinfeida Pharmaceutical Indapamide Product Portfolio
  54. 7.9.5 Shandong Yinfeida Pharmaceutical Recent Developments
  55. 7.10 Suzhou Lixinpharm
  56. 7.10.1 Suzhou Lixinpharm Company Information
  57. 7.10.2 Suzhou Lixinpharm Business Overview
  58. 7.10.3 Suzhou Lixinpharm Indapamide Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Suzhou Lixinpharm Indapamide Product Portfolio
  60. 7.10.5 Suzhou Lixinpharm Recent Developments
  61. 7.11 Teva
  62. 7.11.1 Teva Company Information
  63. 7.11.2 Teva Business Overview
  64. 7.11.3 Teva Indapamide Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Teva Indapamide Product Portfolio
  66. 7.11.5 Teva Recent Developments
  67. 7.12 Lisheng Pharma
  68. 7.12.1 Lisheng Pharma Company Information
  69. 7.12.2 Lisheng Pharma Business Overview
  70. 7.12.3 Lisheng Pharma Indapamide Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Lisheng Pharma Indapamide Product Portfolio
  72. 7.12.5 Lisheng Pharma Recent Developments
8 North America
  1. 8.1 North America Indapamide Market Size by Type
  2. 8.1.1 North America Indapamide Revenue by Type (2021-2032)
  3. 8.1.2 North America Indapamide Sales by Type (2021-2032)
  4. 8.1.3 North America Indapamide Price by Type (2021-2032)
  5. 8.2 North America Indapamide Market Size by Application
  6. 8.2.1 North America Indapamide Revenue by Application (2021-2032)
  7. 8.2.2 North America Indapamide Sales by Application (2021-2032)
  8. 8.2.3 North America Indapamide Price by Application (2021-2032)
  9. 8.3 North America Indapamide Market Size by Country
  10. 8.3.1 North America Indapamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Indapamide Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Indapamide Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Indapamide Market Size by Type
  2. 9.1.1 Europe Indapamide Revenue by Type (2021-2032)
  3. 9.1.2 Europe Indapamide Sales by Type (2021-2032)
  4. 9.1.3 Europe Indapamide Price by Type (2021-2032)
  5. 9.2 Europe Indapamide Market Size by Application
  6. 9.2.1 Europe Indapamide Revenue by Application (2021-2032)
  7. 9.2.2 Europe Indapamide Sales by Application (2021-2032)
  8. 9.2.3 Europe Indapamide Price by Application (2021-2032)
  9. 9.3 Europe Indapamide Market Size by Country
  10. 9.3.1 Europe Indapamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Indapamide Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Indapamide Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Indapamide Market Size by Type
  2. 10.1.1 China Indapamide Revenue by Type (2021-2032)
  3. 10.1.2 China Indapamide Sales by Type (2021-2032)
  4. 10.1.3 China Indapamide Price by Type (2021-2032)
  5. 10.2 China Indapamide Market Size by Application
  6. 10.2.1 China Indapamide Revenue by Application (2021-2032)
  7. 10.2.2 China Indapamide Sales by Application (2021-2032)
  8. 10.2.3 China Indapamide Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Indapamide Market Size by Type
  2. 11.1.1 Asia Indapamide Revenue by Type (2021-2032)
  3. 11.1.2 Asia Indapamide Sales by Type (2021-2032)
  4. 11.1.3 Asia Indapamide Price by Type (2021-2032)
  5. 11.2 Asia Indapamide Market Size by Application
  6. 11.2.1 Asia Indapamide Revenue by Application (2021-2032)
  7. 11.2.2 Asia Indapamide Sales by Application (2021-2032)
  8. 11.2.3 Asia Indapamide Price by Application (2021-2032)
  9. 11.3 Asia Indapamide Market Size by Country
  10. 11.3.1 Asia Indapamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Indapamide Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Indapamide Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Indapamide Market Size by Type
  2. 12.1.1 SAMEA Indapamide Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Indapamide Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Indapamide Price by Type (2021-2032)
  5. 12.2 SAMEA Indapamide Market Size by Application
  6. 12.2.1 SAMEA Indapamide Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Indapamide Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Indapamide Price by Application (2021-2032)
  9. 12.3 SAMEA Indapamide Market Size by Country
  10. 12.3.1 SAMEA Indapamide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Indapamide Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Indapamide Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Indapamide Value Chain Analysis
  2. 13.1.1 Indapamide Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Indapamide Production Mode & Process
  6. 13.2 Indapamide Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Indapamide Distributors
  9. 13.2.3 Indapamide Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst